Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

Clinical trial NCT00497081 · COMPLETED

Trial details

NCT number: NCT00497081
Sponsor: San Francisco Department of Public Health
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Substance Abuse HIV Infections

Start date: 2007-05-01
Primary completion: 2010-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.